Diagenode

CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells.


Bommi-Reddy A. et al.

Therapeutic targeting of the estrogen receptor (ER) is a clinically validated approach for estrogen receptor positive breast cancer (ER+ BC), but sustained response is limited by acquired resistance. Targeting the transcriptional coactivators required for estrogen receptor activity represents an alternative approach that is not subject to the same limitations as targeting estrogen receptor itself. In this report we demonstrate that the acetyltransferase activity of coactivator paralogs CREBBP/EP300 represents a promising therapeutic target in ER+ BC. Using the potent and selective inhibitor CPI-1612, we show that CREBBP/EP300 acetyltransferase inhibition potently suppresses in vitro and in vivo growth of breast cancer cell line models and acts in a manner orthogonal to directly targeting ER. CREBBP/EP300 acetyltransferase inhibition suppresses ER-dependent transcription by targeting lineage-specific enhancers defined by the pioneer transcription factor FOXA1. These results validate CREBBP/EP300 acetyltransferase activity as a viable target for clinical development in ER+ breast cancer.

Tags
IP-Star
Antibody
Microplex Library Preparation kit
iDeal ChIP-seq Kit for Histones
Chromatin Profiling (ChIP-seq) Services

Share this article

Published
March, 2022

Source

Products used in this publication

  • default alt
    G02010000
    ChIP-seq/ChIP-qPCR プロファイリングサービス
  • ChIP kit icon
    C01010051
    iDeal ChIP-seq kit for Histones
  • Bioruptor Pico
    B01080010
    Picoruptor 2 sonication device
  • Compact Automated System
    B03000002
    SX-8G IP-Star® Compact Automated System
  • some alt
    C30010016
    1.5 ml Picoruptor Microtubes with Caps
  • ChIP-seq Grade
    C15410004
    H3K9ac polyclonal antibody
  • cut and tag antibody icon
    C15410196
    H3K27ac polyclonal antibody
  • ChIP kit icon
    C05010012
    MicroPlex Library Preparation Kit v2 (12 indices)

イベント

  • IMB Conference on "Epigenetics of Ageing - Responses to Adversity across Scales" 2022
    Rheinland-Pfalz, Germany
    Jun 28-Jul 1, 2022
  • CNET 2022
    Gif-Sur-Yvette, France
    Jul 4-Jul 6, 2022
 すべてのイベントを見る

ニュース

 すべてのニュースを見る


The European Regional Development Fund and Wallonia are investing in your future.

Extension of industrial buildings and new laboratories.


       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy   |   Diagenode Diagnostics